 |
|
| INTERNATIONAL JOURNAL OF PHARMACEUTICS
| |
| | |
|
|
Editors-in-Chief:
A.T. Florence, J.H. Rytting
See editorial board for all editors information
SIGN UP FOR THE PHARMACEUTICAL SCIENCES NEWSLETTER
here
Description
The International Journal of Pharmaceutics publishes innovative papers, reviews, mini-reviews, rapid
communications and notes dealing with physical, chemical, biological, microbiological and engineering studies related to the conception,
design, production, characterisation and evaluation of drug delivery systems in vitro and in vivo. "Drug" is defined
as any therapeutic or diagnostic entity, including oligonucleotides, gene constructs and radiopharmaceuticals.
Areas of particular
interest include: physical pharmacy; polymer chemistry and physical chemistry as applied to pharmaceutics; excipient function and characterisation;
biopharmaceutics; absorption mechanisms; membrane function and transport; novel routes and modes of delivery; responsive delivery systems,
feedback and control mechanisms including biosensors; applications of cell and molecular biology to drug delivery; prodrug design; bioadhesion
(carrier-ligand interactions); and biotechnology (protein and peptide formulation and delivery).
Editorial Policy
The
over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not
sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although
the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple
authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript
has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried
out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the
consent of the Editors and Publisher.
Authors must state in a covering letter when submitting papers for publication the novelty
embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No
paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the
performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin
to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles.
Bibliographic & ordering information
ISSN: 0378-5173
Imprint: ELSEVIER
Commenced publication 1978
Subscriptions for the year 2008,
Volumes 345-363,
38 issues
Also available as part of the Pharmacology Package - Option 2
Institutional online access: ScienceDirect eSelect
For purchase of online access to this journal on ScienceDirect.
Institutional price: Order form
USD 8,904 for all countries except Europe, Japan and Iran
EUR 7,959 for European countries and Iran
JPY 1,057,200 for Japan
Associated personal price: Order form
JPY 72,900 for Japan
USD 602 for all countries except Europe, Japan and Iran
EUR 539 for European countries and Iran
Conditions of sale & ordering procedures, and links to our regional sales offices.
For an overview of recently-dispatched issues, see the Journal issue
dispatch dates
Audience
Pharmaceutical Scientists, Clinical Pharmacologists, Chemical Engineers, Biotechnologists.
Impact factor of this journal
2007: 2.408 ....increased from 2.039 in 2004
© Journal Citation Reports 2008, published by Thomson Reuters
602/188
Last update: 30 Jun 2008
|
|
| |
| | |
|
|
| |
